好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association of EEG Findings with Clinical Outcome in Patients with Encephalitis
Epilepsy/Clinical Neurophysiology (EEG)
P14 - Poster Session 14 (11:45 AM-12:45 PM)
10-004

To assess the association between EEG findings and final clinical outcomes in patients diagnosed with encephalitis 

Encephalitis is associated with high rates of mortality and morbidity; causing death in 5.6-20% of patients admitted to the hospital. Forty percent of patients with encephalitis manifest with seizures (sz). Sz have have an impact on final prognosis, and as such, EEG acquisition has been recommended in all patients with encephalitis. 

Patients from university hospitals affiliated with The University of Texas Health Science Center at Houston with a final diagnosis of encephalitis between 2005-2016 were included. Clinical data was retrospectively collected. Clinical outcomes were defined by the Glasgow Outcome Scale (GOS): GOS ≥13 was deemed favorable, and GOS<13 was unfavorable. Timing, number, and EEG reports were abstracted for findings. Statistical analysis included Chi-square and ANOVA tests. 

Of the 340 patients, 42.9% women, with a mean age 48.6 years old. Breakdown of etiology included autoimmune with positive antibodies in 10% and infectious in 36.4%. 143 patients had EEG performed, 26 were monitored with continuous video EEG (cvEEG). 86% had abnormal EEG in first recording, which was associated with a worse outcome, particularly in presence of slow background (p<0.05). Rhythmic patterns and seizure activity on EEG did not correlate with poor outcome (p>0.05). Sz were only captured in 17 patients and were noted on first EEG in 52%. In 70%, sz were captured during cvEEG.  

We demonstrated that abnormal background activity in the first EEG is associated with poor outcomes. Unlike prior studies, our cohort did not demonstrate worse outcomes with sz, which may be due to low number of patients with an EEG-captured sz. Given that cvEEG was utilized in a limited number of patients, with a majority of seizures reported during cvEEG, we suggest lower threshold for long-term monitoring in patients with suspected encephalitis.   

Authors/Disclosures
Shirin Jamal Omidi, MD (Mayo Clinic)
PRESENTER
Dr. Jamal Omidi has nothing to disclose.
Rohini D. Samudralwar, MD (The University of Pennsylvania) Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Katherine M. Harris, MD Dr. Harris has nothing to disclose.
Shivika Chandra, MD, FAAN (University of Texas Health Science Center at Houston) The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in 好色先生 Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Rodrigo Hasbun Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux.